id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
983612,c7953482-ff82-4127-9447-bbf6a7aa30c8,Q3,MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE),400265214,MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE),2010,third_quarter,MED,Issues related to federally sponsored research and funding for NIH research,"Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,265000,0,0,2010-07-21T12:53:51.217000-04:00
987158,65aef62f-005a-40c4-bb29-27ebca4042ae,Q3,PERSONALIZED MEDICINE COALITION,40046362,PERSONALIZED MEDICINE COALITION,2010,third_quarter,MED,"CER, CMS, Coverage of Genetic Testing","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-09-27T14:49:44.573000-04:00
987349,6b689e71-bbbc-47ff-b030-dd3a86f04b0a,Q3,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2010,third_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2010-10-01T10:52:29.323000-04:00
987369,dd88bb97-c65b-471f-9e47-c5c6a13a8af0,Q3,MARSHALL BRACHMAN,6848,CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE,2010,third_quarter,MED,"support HR 1293/S. 1338 equivalent in 111th Congress
reverse cardiac catheterization practice expense cuts","HOUSE OF REPRESENTATIVES,SENATE",12000,,0,0,2010-10-01T11:41:39.657000-04:00
987375,278ca093-f161-451a-b2d1-b5d851d68325,Q3,MARSHALL BRACHMAN,6848,ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC,2010,third_quarter,MED,oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging in HR 3200 and equivalent Senate legislation; support HR 4173 to reverse cuts in 2010 PFS rule,"HOUSE OF REPRESENTATIVES,SENATE",9000,,0,0,2010-10-01T11:52:40.977000-04:00
987590,2ee8d580-fd6c-4d02-b613-7cd27e545d53,Q3,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2010,third_quarter,MED,all issues related to pharmaceutical labeling,,25000,,0,0,2010-10-04T11:20:26.507000-04:00
987604,06bcb41c-ee11-4f15-ad23-3671c6cc3e0e,Q3,ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH,113,ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH,2010,third_quarter,MED,Advocacy for medical imaging and bioengineering research,"HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2010-10-04T12:05:20.027000-04:00
987776,52bc8cf1-6477-4697-bac7-f9aa1116a429,Q3,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2010,third_quarter,MED,"Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2010-10-05T11:56:29.520000-04:00
987777,699299ce-560f-4b82-a24e-a98398df7a87,3T,"LAWRENCE J. SMITH, P.A.",35775,NATIONWIDE LABORATORY SERVICES,2010,third_quarter,MED,Medicare - End Stage Renal Disease.,"HOUSE OF REPRESENTATIVES,SENATE",5000,,0,1,2010-10-05T11:57:45.273000-04:00
987827,1348ea3a-64fa-4c7e-9447-59b439b32479,Q3,HOLLAND & KNIGHT LLP,18466,"FOUNDATION MEDICINE, INC.",2010,third_quarter,MED,Legislation and regulations governing oversight of genetic tests.  Discussed proposed intellectual property legislation governing gene patents.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-05T13:43:05.730000-04:00
988162,2691ef7e-db6e-4c93-9d75-55d2d0896b99,3T,HOLLAND & KNIGHT LLP,18466,"Q THERAPEUTICS, INC.",2010,third_quarter,MED,Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2010-10-06T12:27:24.620000-04:00
988194,dfdc15b1-ca33-4472-b50f-480999a12e51,Q3,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2010,third_quarter,MED,Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",60000,,0,0,2010-10-06T12:58:47.537000-04:00
988226,b81a2c08-af8b-4142-8908-af13af66fa95,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2010,third_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",47000,,0,0,2010-10-06T13:24:07.167000-04:00
988231,6e6aaa5a-2eaa-43db-aafa-cb756dbc94fd,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2010,third_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",47000,,0,0,2010-10-06T13:27:10.950000-04:00
988233,10d4beda-3dfe-44e6-a216-752c04a64889,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,"PULMATRIX, INC.",2010,third_quarter,MED,"Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Executive Office of the President (EOP),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS)",16000,,0,0,2010-10-06T13:29:12.920000-04:00
988345,2e946b95-faa3-42f0-914d-097bb0bfb225,Q3,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2010,third_quarter,MED,Funding for USDA Agricultural Research Service human nutrition centers in the FY2011 Agricultural Appropriations bill,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-06T15:37:20.707000-04:00
988358,6b3d7b2e-ef32-422c-9000-3dbb7f714c43,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2010,third_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,64750,0,0,2010-10-06T15:52:22.300000-04:00
988920,a1a4a2e0-a3cb-419a-ba31-da706a582909,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2010,third_quarter,MED,"S. 3686,Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010 - Support funding for medical treatment for HIV positive patients.  Not introduced. 

Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-08T11:03:11.293000-04:00
989053,601956aa-32a2-4a01-ab4b-ac08f670d02e,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PARENT PROJECT MUSCULAR DYSTROPHY,2010,third_quarter,MED,"Reauthorization for the Muscular Dystrophy Care Act
Funding for CDC, NIH, HHS, and FDA related to Muscular Dystrophy and other health research","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2010-10-08T13:42:55.120000-04:00
989400,db50ffd3-1757-4a8c-b517-d0ac20e6d9c8,Q3,BEN BARNES GROUP LP,5415,HUNTSMAN CANCER INSTITUTE,2010,third_quarter,MED,Assistance with issues relating to medical research,"HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2010-10-08T18:56:43.090000-04:00
989417,81d7081a-cdc6-4c97-b1d2-bfe9f3b9fd90,Q3,BEN BARNES GROUP LP,5415,OKLAHOMA RESEARCH MEDICAL FOUNDATION,2010,third_quarter,MED,Issues relating to medical research,"HOUSE OF REPRESENTATIVES,SENATE",26800,,0,0,2010-10-09T12:05:56.817000-04:00
989435,faa792df-8810-413d-8f32-8bf1f8432ab3,Q3,BOB MOSS ASSOCIATES,51877,BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH),2010,third_quarter,MED,"Securing continued federal support for Sanford Burnham's medical research, including the Depeartment of Defense Appropriations Bill for FY11 (not yet introduced).","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-10-09T13:26:12.393000-04:00
989594,e77944ae-f5c5-4d56-a9ce-de65adbc3145,Q3,MAYO CLINIC,400270238,MAYO CLINIC,2010,third_quarter,MED,"Funding for Alzheimers Disease research in DOD funding
FDA rules relating to lab developed testing
Funding for medical simulation","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,190000,0,0,2010-10-11T11:35:11.720000-04:00
989772,0027a4bd-0fc4-42b2-a23c-9fc2a28de7d2,Q3,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2010,third_quarter,MED,"FY 2010 Appropriations                                                      S. 588; H.R. 1093 Residency Caps
H.R. 3; S. 5; S. 30 Stem Cell                                               S. 1576 Minority Improvement
S. 1066 Medical Affordability Act                                     H. R. 1788, S. 458 False Claims Correction Act
S. 484 Research Misconduct Clinical Trials                     NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act (H.R. 1548)
Prevention Research Centers
Resident Physician Shortage Reduction Act of 2009
Health Care Reform (H.R. 3590)","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,110000,0,0,2010-10-11T16:35:15.390000-04:00
989897,7d65f347-dd02-45c6-8e9a-1707e17ed0a3,Q3,"THE PETRIZZO GROUP, INC.",305932,"AGIOS PHARMACEUTICALS, INC.",2010,third_quarter,MED,Advance proposal for federal funding in the FY 2011 Defense Appropriations bill for cancer metabolism drug discovery that will bring therapeutic hope to service men and women who are suffering from Acute Lyeloid Leukemia and brain cancer (gliomas).,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-12T09:58:36.890000-04:00
989934,d5d11f42-7e2a-4240-bc3e-2c27cc9a2d49,Q3,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2010,third_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2010: Provisions relating to disease research","Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2010-10-12T10:13:42.847000-04:00
989955,69a07f54-1ee7-4b8a-85e4-4c259e440131,Q3,HOLLAND & KNIGHT LLP,18466,AABB,2010,third_quarter,MED,Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS.,"Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-12T10:24:15.027000-04:00
989959,d64263d2-40b8-4bf5-a436-c598d5cd8bd0,Q3,HOLLAND & KNIGHT LLP,18466,AMERICAN SOCIETY OF HEMATOLOGY,2010,third_quarter,MED,"Labor, HHS, Education Appropriations bills; hematology  and hematology/oncology public health and research issues; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-10-12T10:25:16.497000-04:00
989991,4473a560-f06b-46ac-80f3-9ebbf50ab45c,Q3,HOLLAND & KNIGHT LLP,18466,NATIONAL HEMOPHILIA FOUNDATION,2010,third_quarter,MED,Biomedical Research; CDC Hemophilia program; HR 4846 SAFE Act,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",40000,,0,0,2010-10-12T10:34:19.177000-04:00
990139,56e75c33-746d-462c-87ff-c2c21f6a86a0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2010,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T12:14:54.020000-04:00
990227,83989e62-b43b-4a56-8c5b-62ba25464aa0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2010,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T12:53:15.847000-04:00
990238,2e4009f0-23b1-4989-b9a4-a5bd119f9e41,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2010,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T13:07:17.187000-04:00
990255,7e0e8b36-0c10-4c72-a8bb-ea358335b822,Q3,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2010,third_quarter,MED,"Department of Vetereans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,68397,0,0,2010-10-12T13:14:19.927000-04:00
990269,c9b098b0-6c17-4099-b847-c39c4f5ad0c7,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2010,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T13:18:30.287000-04:00
990345,1ab2ac1e-a09b-48b5-a273-c4d171d0bae9,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2010,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2010-10-12T14:13:03.877000-04:00
990509,9b09b731-cb9e-4bf2-b8cc-086cfdddae3d,Q3,MICHAEL SAULS,43638,MIT HOLDING INC,2010,third_quarter,MED,"Educating Congress and regulatory agencies about client's products, seeking EPA registration.","Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-12T15:49:04.247000-04:00
990644,f78106b9-b979-4ea9-86ed-f2af86c82100,Q3,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2010,third_quarter,MED,Legislation and issues related to Alzheimer's Disease Research,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office",10000,,0,0,2010-10-12T17:38:29.870000-04:00
990718,a8c03f1b-4fe3-48fd-9df5-f19ede6d8c10,Q3,CEPHEID,400270233,CEPHEID,2010,third_quarter,MED,"See page five HR 1 American Recovery and Reinvestment Act of 2009
HR 805 / S 1028 Strengthening America's Public Health System Act
H.R. 1105 FY 2009 Omnibus Appropriations Act
HR 1321 Healthy Americans Act
HR 1452 Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009
HR 1699 / S 1220 Patient Access to Critical Lab Tests Act
HR 2400 Strategies to Address Antimicrobial Resistance Act
HR 2502 Comparative Effectiveness Research Act of 2009
HR 2824 Doctor-Patient Relationship and Research Protection Act
HR 2937/ S 1305 MRSA Infection Prevention and Patient Protection Act
HR 3104 Healthy Hospitals Act of 2009
HR 3002 / S 1259 PATIENTS Act of 2009
HR 3200 America's Affordable Health Choices Act of 2009
HR 3590 Patient Protection and Affordable Care Act
HR 3962 Affordable Health Care for America Act
S 1208 Strengthening America's Public Health System Act
S 1213 Patient-Centered Outcomes Research Act of 2009
S 1220 Patient Access to Critical Lab Tests Act
S 1299 Worker Infection Protection Act
S. 1679 Affordable Health Choices Act
S. 1796 America's Healthy Future Act of 2009","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE",,20000,0,0,2010-10-12T19:17:49.737000-04:00
991010,3b24d0c7-1161-40ca-92ed-6225197e99e3,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,COOLEY'S ANEMIA FOUNDATION,2010,third_quarter,MED,Drug review and approval process,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-13T11:13:18.690000-04:00
991039,20dc8dfa-ce9e-459d-909f-9eb33695cbba,Q3,"RICHARD J. LEIDL, P.C.",400359637,UNIVERSITY OF TEXAS MEDICAL BRANCH,2010,third_quarter,MED,Funding under various Federal grant programs.,,,,0,0,2010-10-13T11:23:33.043000-04:00
991426,dbe0f1e4-c6cc-4193-a1bb-44175b39224f,Q3,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,314055,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,2010,third_quarter,MED,Support for the National Institutes of Health; Support for the National Eye Institute; Support for medical research programs at the Department of Defense,"HOUSE OF REPRESENTATIVES,SENATE",,81000,0,0,2010-10-13T14:05:12.280000-04:00
991707,fc3963ee-838a-46d6-b14f-b731c1882da9,Q3,"PAUL MARCONE & ASSOCIATES, LLC",283732,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2010,third_quarter,MED,Getting Congress to stop federal funding of a specific grant awarded by NASA for radiation studies involving the use of live squirrel monkeys and designed to predict radiation risks for astronauts during deep space travel.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-13T15:43:40.033000-04:00
991969,c41fb72c-2b90-4368-9b6b-7c43f0099975,Q3,THE HARRIS FIRM,68376,DIRECT MESSAGE LAB,2010,third_quarter,MED,Regarding funding for FY 11 pertaining to software communication system for chronic disease management,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-13T17:39:24.633000-04:00
992049,746f4d14-cadb-45d1-aa9a-c55ec7405c3d,Q3,"THE PETRIZZO GROUP, INC.",305932,ALLEN INSTITUTE,2010,third_quarter,MED,"Advocated for federal funding in the FY 2011 Labor HHS Appropriations bill for the Allen Institute Human Brain Atlas Project, which will create a comprehensive 3-dimensional map detailing gene expression in the human brain.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-13T21:32:01.683000-04:00
992059,004baa23-673e-4d89-864e-37a07c73eca4,Q3,"THE PETRIZZO GROUP, INC.",305932,BENAROYA RESEARCH INSTITUTE,2010,third_quarter,MED,"Advocated for federal funding in FY 2011 DoD Appropriations bill to develop personalized disease therapies based on genetic phenptype identification and specialized pre-symptomatic therapy for autoimmune disease.
Advocated for federal funding in FY 2011 LHHS Appropriations bill for critical multi-project animal care infrastructure.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-13T21:59:06.043000-04:00
992315,45064ba8-40aa-42cc-96ec-f1a6b84d89ac,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2010,third_quarter,MED,Appropriations and Authorization legislation for FY 2011 in health care,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2010-10-14T10:32:28.867000-04:00
992444,4c35569b-6232-4504-807d-23f814a4ed13,Q3,AMERICAN SOCIETY FOR MICROBIOLOGY,3355,AMERICAN SOCIETY FOR MICROBIOLOGY,2010,third_quarter,MED,"WMD Prevention and Preparedness Act, HR 5498",HOUSE OF REPRESENTATIVES,,,0,0,2010-10-14T11:10:57.943000-04:00
992618,03c19722-2fa8-4399-a1e7-b0b20aa114eb,Q3,"BALCH & BINGHAM, LLP",5197,BIOCRYST PHARMACEUTICALS INC,2010,third_quarter,MED,Federal response to the pandemic influenza outbreak and pandemic preparedness.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-14T11:57:48.497000-04:00
992645,fe823606-f2eb-41fd-9cff-9bdf1d79b9e1,Q3,CLARK & WEINSTOCK,9443,AUSTEN BIOINNOVATION INSTITUTE,2010,third_quarter,MED,Funding for medical research; health policy.,"Army, Dept of (Other),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Science & Technology Policy (OSTP),SENATE",20000,,0,0,2010-10-14T12:05:03.767000-04:00
992810,d6d504af-5277-404e-9f48-63b31c206b9a,Q3,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2010,third_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-14T12:47:52.400000-04:00
993003,7d5fd5fa-6284-41b6-b904-e6e6a5e9d8bf,Q3,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2010,third_quarter,MED,"NIH Budget including Title VII & VIII programs
VA-Outpatient Clinic in N.C.(RFP-land acquisition)
Great Ape Protection Act (H.R.1326)","Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)",,160000,0,0,2010-10-14T13:43:47.167000-04:00
993500,3af66a64-1cc1-43ee-8ad8-9ecba2ca35e2,Q3,AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE (ASRM),306897,AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE (ASRM),2010,third_quarter,MED,stem cell research,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-14T15:55:00.803000-04:00
993514,3ec8a44c-cab7-4fe3-9f97-a67199a65fb5,Q3,WASHINGTON UNIVERSITY IN ST. LOUIS,40031264,WASHINGTON UNIVERSITY IN ST LOUIS,2010,third_quarter,MED,"General advocacy for NIH research; improved conflict of interest policies.  Advocacy to increase awareness of efforts to combat the problem of obstetric fistula in Sub-Saharan Africa.  Advocacy in support of federal stem cell research.  S. 3694 -- Great Ape Protection Act of 2010 -- To prohibit the conducting of invasive research on great apes, and for other purposes. General advocacy.","Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Science & Technology Policy (OSTP),SENATE",,50000,0,0,2010-10-14T16:01:23.637000-04:00
993565,1af8c60f-4ba4-4fd3-8518-658fa20dc603,Q3,MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP),24486,"BIOCRYST PHARMACEUTICALS, INC.",2010,third_quarter,MED,Federal response to the H1N1 influenze pandemic and overall prepardness,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-14T16:20:24.243000-04:00
993854,bf1f1344-2d10-4616-b060-5257a593e2a2,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL PSORIASIS FOUNDATION,2010,third_quarter,MED,"H.R. 930/S. 571- Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2009","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",50000,,0,0,2010-10-14T18:09:56.337000-04:00
993861,ed507831-b708-4994-b05c-8b243fb645b7,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2010,third_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2010-10-14T18:13:59.187000-04:00
993877,ad9ba201-a1ec-4d2b-953a-7651dc9139e4,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,OVARIAN CANCER NATIONAL ALLIANCE,2010,third_quarter,MED,Ovarian Cancer Research and Awareness; H.R. 2941/S. 3493 - To Reauthorize and Enhance Johanna's Law to Increase Public Awareness and Knowledge with Respect to Gynecologic Cancers.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-14T18:25:06.913000-04:00
993878,bf77a75e-7bbb-48a8-bce1-9236257f16ce,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,RIVERAIN MEDICAL,2010,third_quarter,MED,Increasing awareness of lung cancer and making it a public health priority,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-14T18:31:08.010000-04:00
993956,5291ccbf-c95d-488b-bfb6-9db632fa4b4c,Q3,"THE PETRIZZO GROUP, INC.",305932,"DESOTO MEMORIAL HOSPITAL, INC.",2010,third_quarter,MED,Advocated for Congressional support of appeak to FEMA regarding use of grant funding to reinforce the hospitals roof.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-14T21:22:36.933000-04:00
993959,dd2b4370-530d-402d-842f-308691616bdd,Q3,"THE PETRIZZO GROUP, INC.",305932,"FATE THERAPEUTICS, INC.",2010,third_quarter,MED,"Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.","HOUSE OF REPRESENTATIVES,SENATE",25000,,0,0,2010-10-14T21:43:38.253000-04:00
994133,b59630f1-ce5b-492d-8295-06cfd8f9e551,Q3,"KSCW, INC.",21596,INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS,2010,third_quarter,MED,"HR1346, S540 Medical Device Safety Act of 2009: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices.",HOUSE OF REPRESENTATIVES,10000,,0,0,2010-10-15T10:44:23.767000-04:00
994287,35a927b8-6908-4cb7-992c-3eb683c90c9b,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,U.S. SOCCER FOUNDATION,2010,third_quarter,MED,"Congressional Soccer Caucus
Federal grants for obesity prevention and gang prevention
S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, anti-obesity programs
H.R. 6258, Fit for Life Act of 2010","Corporation for Natl & Community Service,Defense, Dept of (DOD),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",10000,,0,0,2010-10-15T11:36:37.697000-04:00
994307,4773abba-30cc-4c0c-807f-cd9462d68d31,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2010,third_quarter,MED,"H.R. - No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, Tuberous Sclerosis
H.R. - No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-10-15T11:41:40.747000-04:00
994438,0909e586-7e72-4932-a3c3-815810c3d83c,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2010,third_quarter,MED,"H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research
H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease
HR 1230, Bone Marrow Failure Disease Research and Treatment Act","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-10-15T12:15:20.287000-04:00
994465,a40de759-791d-4fa1-8fdd-17c73738ea2f,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,UNIVERSITY LABORATORY CONSORTIUM FOR BIODEFENSE AND PANDEMIC PREPAREDNESS,2010,third_quarter,MED,"Federal funding for biodefense research
S. 3607, Homeland Security Appropriations Bill, FY 2011, funding for biosafety laboratory surge capacity
HR 1150, Laboratory Surge Capacity Preparedness Act
HR 5498/S 1649, the Weapons of Mass Destruction Prevention and Preparedness Act","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-15T12:23:25.807000-04:00
994477,2892a250-700b-433f-a728-b55b8dfb3fac,Q3,"HEALTHFUTURES, LLC",400359646,LIFE TECHNOLOGIES,2010,third_quarter,MED,"HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
No Bill#, Genomic Research and Accessibility Act, DNA patents
HR 805, Strengthening America's Public Health System Act, Pandemic influenza","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS)",50000,,0,0,2010-10-15T12:30:27.077000-04:00
994489,5bcf40d5-e07b-43be-aead-57a9403068d2,Q3,"HEALTHFUTURES, LLC",400359646,ASSOCIATION FOR MOLECULAR PATHOLOGY,2010,third_quarter,MED,"Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics
HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE",30000,,0,0,2010-10-15T12:34:31.657000-04:00
994499,ef4b2a3b-cb09-4555-b815-cc0c2edaa6d1,Q3,"HEALTHFUTURES, LLC",400359646,"NAVIGENICS, INC.",2010,third_quarter,MED,"Oversight and regulation of genetic testing
Direct to consumer genetic testing","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-15T12:39:33.913000-04:00
994967,294f4727-2048-4517-9a62-2289efe4ff2c,Q3,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,66911,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,2010,third_quarter,MED,"Lobbied Members of Congress for additional nursing research funding in the FY 2011 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, and the Agency for Healthcare Research and Quality.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Indian Health Service,Interior, Dept of (DOI),Natl Institutes of Health (NIH),SENATE",,20000,0,0,2010-10-15T15:12:46.187000-04:00
995772,5f4aba9c-eea6-4649-9e79-eed564b6fa4b,Q3,"M.J. SIMON & COMPANY, LLC",40026223,AXOGEN INC.,2010,third_quarter,MED,Food and Drug Act,"HOUSE OF REPRESENTATIVES,SENATE",36000,,0,0,2010-10-16T09:54:50.820000-04:00
995858,42a32cfa-7afc-4a31-9692-a7f2658ed251,Q3,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2010,third_quarter,MED,Advocated in support of the 21st Century Cancer ALERT Act (S. 717).,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-16T19:17:05.907000-04:00
995862,d12a7749-d882-42bf-bcc4-e9e298c00f0b,Q3,"THE PETRIZZO GROUP, INC.",305932,ORLANDO HEALTH,2010,third_quarter,MED,"As the Pediatric Neuroscience Institute at the Arnold Palmer Hospital for Children continues to align the services provided with the needs of the Central Florida community, this capability was identified as one that could dramatically improve the quality of life of children in the area. To eliminate wait times of 8-10 weeks and provide more advanced imaging services to patients, we are seeking funding to purchase a 3 Tesla MRI, which has substantially greater diagnostic capabilities than the current unit and would benefit all of the key service that support patients.

Orlando Healths Childrens Advocacy Center program. Advocate for federal funding that will ensure that the thousands of families that experience child abuse each year in Orange County, Florida are able to access the services needed to help them recover and heal. Funding will be used to sustain existing child advocates and therapists, and other costs, as well as expand the programs capacity to provide services, with the addition of two child advocates and four therapists. This will expand access to vital rehabilitation and recovery services for victims of child abuse. 

Orlando Healths M.D. Anderson Cancer Center Nano-medicine for Radiation Protection of U.S. Armed Forces. Advocate for federal funding to support a drug discovery program to improve the survival of, provide faster recovery for, and limit or eliminate drug side effects experienced by US military men and women after exposure to high levels of radiation. The funding will be used to create a platform where scientists can study the effect of radiation on nanoparticles with or without cells. Specifically, scientists will identify the form of nanoceria that provides the most effective level of radioprotection. This research will ultimately lead to the development of an effective drug for the treatment of radiation exposure for military personnel who are exposed to high doses of radiation during service to our country. This will be the first feasibility study of the effect of nano-medicine for radioprotection. The requested fudning will finance research on radioprotection for soldiers, and ultimately civilians, who must undergo radiation therapies for illnesses.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-16T19:22:08.597000-04:00
995870,10c637b1-00ef-4fea-8a33-03f922f8c32b,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE BIOMEDICAL RESEARCH INSTITUTE,2010,third_quarter,MED,Advocate for federal funding in the FY 2011 Defense Appropriations bill to support next - generation drug development for Leishmaniasis.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-16T19:30:11.903000-04:00
995883,e4d92ee3-c1c4-4b45-88bd-a8cf8fcc8927,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CANCER CARE ALLIANCE,2010,third_quarter,MED,"Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers.  Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-16T19:51:18.257000-04:00
995886,3d005e0f-828e-481f-ba47-9938bc7edf5b,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2010,third_quarter,MED,"Advocate for federal funding for GAPPS Project -- Understanding Increased Risk of Preterm Birth and Stillbirth in a Post-Combat Setting.  This request is aimed at improving our understanding of factors which contribute to preterm and stillbirths around the world.  Specifically, federal funding would examine how and whether poor nutrition, impoverishment, the high stress of living in war-torn areas, and exposure to various toxins and pathogens increase rates of preterm birth and stillbirth rates.  This project will provide the U.S. Army with research that will inspire new diagnostics, therapeutics and other innovations to improve birth outcomes and prevent prematurity and stillbirths. This research will extrapolate to a broader range of maternal health conditions as they relate to the priorities of the Department of Defense for warfighter health","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-16T19:55:19.637000-04:00
995970,50d0cf48-027a-4d5a-8af4-4e51b205cb58,Q3,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS,2010,third_quarter,MED,"Drug development for ocular infections, TBI/stroke related conditions, and HIV","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2010-10-17T10:45:41.160000-04:00
995976,a7d54a48-ae95-40ad-861a-f326486fa8f1,Q3,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF TRIUS THERAPEUTICS,2010,third_quarter,MED,"Antibiotics, BioDefense","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2010-10-17T10:51:44.133000-04:00
995987,879adba0-d143-499b-b662-876b30cfd842,Q3,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF VARIATION BIOTECHNOLOGIES,2010,third_quarter,MED,Funding and parnerships with the Department of Defense and Department of Health and Human Services for vaccine research and development,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Natl Institutes of Health (NIH)",,,0,0,2010-10-17T10:58:50.343000-04:00
996082,52f584ce-ac0d-446d-b6fd-0813df93b8e3,Q3,"CAPITOL CONSULTING GROUP, LLC",400366700,LIFECELL CORPORATION,2010,third_quarter,MED,"FY 11 defense appropriations bill, Army medical research and development project","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-17T17:28:17.110000-04:00
996144,641f3b31-a08d-4f54-b8bc-0119abdab58f,3T,SQUIRE PATTON BOGGS,30906,AD HOC COALITION TO PRESERVE CLINICAL LABORATORY SERVICES,2010,third_quarter,MED,"H.R. 3590 Patient Protection and Affordable Care Act
H.R. 3962 Affordable Health Care for America Act
H.R. 3200  America's Affordable Health Choices Act of 2009
S. 1796 America's Healthy Future Act","HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2010-10-18T06:48:52.237000-04:00
996548,80067478-5e39-4c95-b67a-c97c59733dc2,Q3,POLICY DIRECTIONS INC.,31747,ADVANCED LIFE SCIENCES,2010,third_quarter,MED,FDA regulatory pathway for new antibiotic medicines.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-18T10:32:03.640000-04:00
996645,54353bf9-30e5-4ee5-bd35-5be4ff20f8dc,Q3,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2010,third_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-18T10:41:31.307000-04:00
996826,5d40ac1a-e915-4a8f-abb2-2efda5420011,Q3,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2010,third_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2010: Provisions relating to disease research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-18T11:05:07.730000-04:00
997304,e76551e4-552e-41fd-8cbe-2e345b7bbffa,3A,POLICY DIRECTIONS INC.,31747,ADVANCED LIFE SCIENCES,2010,third_quarter,MED,FDA regulatory pathway for new antibiotic medicines.,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-18T12:18:31.040000-04:00
997415,a505e3cb-e7f4-48da-a74a-e2c8732dc278,Q3,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,400382759,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2010,third_quarter,MED,"Urging members of Congress to co-sponsor H.R. 1326 and S. 3694, the Great Ape Protection Act, which would phase out invasive research on chimpanzees and retire chimpanzees owned by the federal government to permanent sanctuaries.","HOUSE OF REPRESENTATIVES,SENATE",,151905,0,0,2010-10-18T12:31:30.980000-04:00
997491,9efd5555-d319-41b4-bd18-36c695d34118,Q3,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,3435,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,2010,third_quarter,MED,"Regulation of  Laboratory Developed Tests
Health Care Reform -- the Patient Protection and Affordable Care Act
Elimination of SGR Formula Under Medicare","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE",,31200,0,0,2010-10-18T12:43:57.277000-04:00
997555,4c325dec-c8ec-48fc-8982-0c1900daaba6,Q3,"ELEVANCE HEALTH, INC.",6484,"ELEVANCE HEALTH, INC.",2010,third_quarter,MED,"General issues related to health care reform, including: cost of care; quality improvements","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,1120000,0,0,2010-10-18T13:01:25.397000-04:00
998136,1a5e6dbc-b47e-4869-a597-a21232a91dcc,Q3,STRATEGIES 360,79175,KORONIS PHARMACEUTICALS,2010,third_quarter,MED,"Sec. 48D Qualifying Therapeutic Discovery Project tax credit
Small Business Innovation Research grant
Grand Challenges grant","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Office of Natl AIDS Policy,SENATE",20000,,0,0,2010-10-18T14:47:00.150000-04:00
998211,411e05a5-aeba-4117-adf0-9eccdb7593f7,Q3,NORTHWESTERN UNIV,299992,NORTHWESTERN UNIV,2010,third_quarter,MED,"HR 1704/S. 682, The Mental Health on Campus Improvement Act, entire bill.
HR 872, Stem Cell Research Improvement Act of 2009, entire bill.
HR 873/S. 487, Stem Cell Research Enhancement Act of 2009, entire bill.
S. 973/HR 2251, Resident Physician Shortage Reduction Act, entire bill.","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2010-10-18T14:53:24.233000-04:00
998312,17ec3cc2-294d-465c-8b44-8db66df32eb6,Q3,RUSS KLENET & ASSOCIATES,400418984,NATIONWIDE LABORATORY SERVICES,2010,third_quarter,MED,Issues relating to medical bundling legislation and clinical laboratories (possibly including provisions in Public Law No. 110-275).,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-18T15:04:59.977000-04:00
998771,a562edd5-6512-4112-add1-510c703a1d4d,Q3,"THE WHITAKER GROUP, INC",312598,SAFE BLOOD INTERNATIONAL FOUNDATION FORMERLY SAFE BLOOD FOR AFRICA FOUNDATION,2010,third_quarter,MED,"To promote interest in, and support for, funding for blood safety programs, such as those conducted by Safe Blood for Africa Foundation, as an important means of preventing the spread of HIV/AIDS and other blood-borne diseases internationally, but primarily in Sub-Saharan Africa.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",20000,,0,0,2010-10-18T16:11:37.680000-04:00
998829,157e37f8-4acc-440b-bf48-d4d982ccb54d,Q3,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2010,third_quarter,MED,Medical Liability; Antimicrobial resistance research; Infectious diseases product research and development; Regulatory science; Unnecessary regulatory burdens placed on medical research; laboratory developed tests; Comparative effectiveness research; and Support for evidence-based decision making.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)",,136124,0,0,2010-10-18T16:20:11.967000-04:00
998860,455051c9-8074-4ff9-8137-e5a7ba14748b,Q3,MARTIN GREEN,400427061,"FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC.",2010,third_quarter,MED,The Genomics and Personalized Medicine Act of 2007; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-18T16:23:10.200000-04:00
998880,192cdcf3-3929-4904-b7d8-42d0c9c0793d,3T,MARTIN GREEN,400427061,FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS,2010,third_quarter,MED,Funding for drug and platform development,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,1,2010-10-18T16:25:18.263000-04:00
999029,fb6eb904-46c5-4792-a63d-451422dab644,Q3,ALERE INC.,400647952,ALERE INC.,2010,third_quarter,MED,Medicare payment for clincical diagnostic laboratory tests.,"HOUSE OF REPRESENTATIVES,SENATE",,110000,0,0,2010-10-18T16:45:20.013000-04:00
999079,ff34e861-679f-44d2-aaf7-5c694486ef6a,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH,2010,third_quarter,MED,Public Health and Research Programs for Infectious and Tropical Disease and Global Health Technologies.,"HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",40000,,0,0,2010-10-18T16:54:02.323000-04:00
999083,d6b8042b-6533-42a3-b46e-40a5c4a72aea,Q3,"ALPINE GROUP PARTNERS, LLC.",1171,AMERICAN COLLEGE OF RADIOLOGY,2010,third_quarter,MED,reauthorization of Mamography Quality Standards Act (MQSA),"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-18T16:54:04.477000-04:00
999124,058b1c77-c0e1-4679-8b17-3a6c11941ee0,Q3,MARTIN GREEN,400427061,FABIANI & COMPANY ON BEHALF OF OCTANE,2010,third_quarter,MED,Funding for innovation accelerator programs and conferences.,"Commerce, Dept of (DOC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Science Foundation (NSF),SENATE,Small Business Administration (SBA)",,,0,0,2010-10-18T16:59:46.043000-04:00
999160,4a18e2a8-dcea-4b98-903c-5c534a76d3cb,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA,2010,third_quarter,MED,Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 5986 - Neglected Infections of Impoverished Americans Act.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-18T17:02:48.900000-04:00
999265,be892607-43db-440a-8737-d038291f0ba3,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREVENT BLINDNESS,2010,third_quarter,MED,Eye Disease; Treatment and Prevention of Blindness and Vision Loss,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-18T17:16:24.463000-04:00